PureTech Health plc (OTCMKTS:PTCHF) Short Interest Down 32.0% in August

PureTech Health plc (OTCMKTS:PTCHF) was the recipient of a significant drop in short interest in August. As of August 31st, there was short interest totalling 16,800 shares, a drop of 32.0% from the August 15th total of 24,700 shares. Based on an average daily volume of 3,300 shares, the days-to-cover ratio is presently 5.1 days.

PureTech Health Price Performance

PTCHF stock remained flat at $1.90 during mid-day trading on Monday. PureTech Health has a one year low of $1.69 and a one year high of $3.00. The business’s fifty day moving average is $2.13 and its 200 day moving average is $2.49.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.